Royalty Pharma PLC 10K Form

Sell

50

RPRX
Royalty Pharma PLC

Last Price:

30.28

Seasonality Move:

1.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-24	10K	RPRX/Royalty Pharma PLC Annual
2020-11-12	10Q	RPRX/Royalty Pharma PLC Quarterly
2020-08-12	10Q	RPRX/Royalty Pharma PLC Quarterly

Receive RPRX News And Ratings

See the #1 stock for the next 7 days that we like better than RPRX

RPRX Financial Statistics

Sales & Book Value

Annual Sales:	$2.24B
Cash Flow:	$607.82M
Price / Cash Flow:	6.23
Annual Sales:	$13.95
Price / Book:	2.16

Profitability

EPS (TTM):	0.11250
Net Income (TTM):	$254.95M
Gross Margin:	$0
Return on Equity:	4.24%
Return on Assets:	1.48%

Royalty Pharma PLC Earnings Forecast

Key Royalty Pharma PLC Financial Ratios

The Gross Profit Margin over the past 11 years for RPRX is 0.00%.
The Selling, General & Administrative Expenses for RPRX have been equal to 10.16% of Gross Profit Margin.
The Research & Development expenses have been 7.92% of Revenue.
The Interest Expense is 438.85% of Operating Income.
The Net Earning history of RPRX is 1.91% of Total Revenues.
Per Share Earnings over the last 18 years have been positive in 9 years.

Royalty Pharma PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Healthcare
Current Symbol:	RPRX
CUSIP:	G7709Q
Website:	royaltypharma.com

Debt

Debt-to-Equity Ratio:	1.13
Current Ratio:	2.52
Quick Ratio:	2.51

Price-to-Earnings

Trailing P/E Ratio:	302.7
Forward P/E Ratio:	7.77

RPRX Technical Analysis vs Fundamental Analysis

Sell

50

Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy or a Sell?

Royalty Pharma PLC stock is rated a Sell
The current Royalty Pharma PLC [RPRX] share price is $30.27. The Score for RPRX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.